Analyst Recommendations

Cowen & Co. analyst issues BUY recommendation for CVS on March 13, 2026 01:26PM ET. The previous analyst recommendation was Buy.CVS was trading at $76.755 at issue of...

March 13, 2026   CVS 1.38%

Bank of America Securities analyst issues BUY recommendation for ADBE on March 13, 2026 01:39PM ET. The previous analyst recommendation was Buy.ADBE was trading at $251.781 at issue...

March 13, 2026   ADBE 0.64%

Piper Sandler analyst issues OUTPERFORM recommendation for LI on March 13, 2026 12:35PM ET. The previous analyst recommendation was Neutral.LI was trading at $17.83 at issue of the...

March 13, 2026   LI 0.49%

Bernstein analyst issues MARKET PERFORM recommendation for LI on March 13, 2026 12:35PM ET. The previous analyst recommendation was Market Perform.LI was trading at $17.83 at issue of...

March 13, 2026   LI 0.49%

Goldman Sachs analyst issues SELL recommendation for ADBE on March 13, 2026 12:31PM ET. The previous analyst recommendation was Sell.ADBE was trading at $269.78 at issue of the...

March 13, 2026   ADBE 0.64%

KeyBanc analyst issues UNDERWEIGHT recommendation for ADBE on March 13, 2026 12:45PM ET. The previous analyst recommendation was Underweight.ADBE was trading at $269.78 at issue of the analyst...

March 13, 2026   ADBE 0.64%

Bernstein analyst issues OUTPERFORM recommendation for ADBE on March 13, 2026 12:40PM ET. The previous analyst recommendation was Outperform.ADBE was trading at $269.78 at issue of the analyst...

March 13, 2026   ADBE 0.64%

Oppenheimer analyst issues PERFORM recommendation for ADBE on March 13, 2026 10:33AM ET. The previous analyst recommendation was Perform.ADBE was trading at $269.78 at issue of the analyst...

March 13, 2026   ADBE 0.64%

UBS analyst issues PERFORM recommendation for ADBE on March 13, 2026 10:33AM ET. The previous analyst recommendation was Perform.ADBE was trading at $269.78 at issue of the analyst...

March 13, 2026   ADBE 0.64%

Wedbush analyst issues OUTPERFORM recommendation for MU on March 13, 2026 10:55AM ET. The previous analyst recommendation was Outperform.MU was trading at $405.35 at issue of the analyst...

March 13, 2026   MU -0.44%